estrogen receptor 1 | OKDB#: 73 |
Symbols: | ESR1 | Species: | human | ||
Synonyms: | ER, ESR, Era, ESRA, ESTRR, NR3A1 | Locus: | 6q25.1-q25.2 in Homo sapiens | HPMR |
For retrieval of Nucleotide and Amino Acid sequences please go to:
OMIM
Entrez Gene
Mammalian Reproductive Genetics Endometrium Database Resource Orthologous Genes UCSC Genome Browser GEO Profiles new! Amazonia (transcriptome data) new! R-L INTERACTIONS MGI |
General Comment |
Estrogen receptors are transcriptional factors with DNA binding domain and a ligand binding domain. Walter et al. (1985) cloned and Greene et al. (1986) sequenced a cDNA for the entire translated portion of the messenger RNA for the estrogen receptor-alpha of MCF-7 human breast cancer cells. Amino acid sequence comparisons showed considerable similarities between human estrogen receptor, glucocortoid and thyroid receptors.
NCBI Summary: This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020] |
||||
General function | Receptor, Nucleic acid binding, DNA binding, Transcription factor | ||||
Comment | |||||
Cellular localization | Nuclear | ||||
Comment | |||||
Ovarian function | Follicle endowment, Follicle development, Preantral follicle growth, Antral follicle growth, Follicle atresia, Ovulation, Steroid metabolism, Luteinization, Luteolysis | ||||
Comment | Complete in vitro generation of fertile oocytes from mouse primordial germ cells. Morohaku K et al. (2016) Reconstituting gametogenesis in vitro is a key goal for reproductive biology and regenerative medicine. Successful in vitro reconstitution of primordial germ cells and spermatogenesis has recently had a significant effect in the field. However, recapitulation of oogenesis in vitro remains unachieved. Here we demonstrate the first reconstitution, to our knowledge, of the entire process of mammalian oogenesis in vitro from primordial germ cells, using an estrogen-receptor antagonist that promotes normal follicle formation, which in turn is crucial for supporting oocyte growth. The fundamental events in oogenesis (i.e., meiosis, oocyte growth, and genomic imprinting) were reproduced in the culture system. The most rigorous evidence of the recapitulation of oogenesis was the birth of fertile offspring, with a maximum of seven pups obtained from a cultured gonad. Moreover, cryopreserved gonads yielded functional oocytes and offspring in this culture system. Thus, our in vitro system will enable both innovative approaches for a deeper understanding of oogenesis and a new avenue to create and preserve female germ cells.////////////////// The Intraovarian Actions of Estrogen Receptor-{alpha} (ER{alpha}) are Necessary to Repress the Formation of Morphological and Functional Leydig-like Cells in the Female Gonad. Couse JF et al. The predisposition of the testis and ovary to primarily synthesize testosterone and estradiol, respectively, is due to gonadal-specific cell types that differentially express the various hydroxysteroid (17beta) dehydrogenase (HSD17B) isoforms. In testes, Leydig cells rely on LH stimulation to maintain expression of the type 3 (HSD17B3) isoform, which specifically converts androstenedione to testosterone. In ovaries, thecal-interstitial cells also rely on LH to induce androgen synthesis but lack HSD17B3 and therefore secrete androgens of low biological activity. Therefore, thecal cells may possess a mechanism to repress the Leydig cell phenotype and HSD17B3 expression. Estradiol is known to inhibit experimentally Leydig cell function and proliferation. In the current study, we provide evidence that estradiol prevents the development of functional Leydig-like cells in the murine ovary; and that this action is mediated by estrogen receptor-alpha (ERalpha). ERalpha-null (alphaERKO) female mice exhibit testis-like levels of Hsd17b3 expression in the ovaries and male-like levels of plasma testosterone. Herein, we demonstrate that a) Hsd17b3 expression in alphaERKO ovaries is a primary effect of the loss of intraovarian ERalpha actions, b) alphaERKO ovarian cells produce substantial levels of testosterone in vitro and this is blocked by a HSD17B3 specific inhibitor, c) Hsd17b3 expression in alphaERKO ovaries is LH regulated and localized to the secondary/thecal interstitial cells, and d) alphaERKO secondary/thecal interstitial cells possess Leydig-like ultrastructural features. These data indicate that intraovarian ERalpha actions are required to repress Hsd17b3 expression in the ovary and may be important to maintaining a female phenotype in secondary/thecal interstitial cells. Estrogen receptor-{alpha} mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17{alpha}-hydroxylase/17,20 lyase) expression. FASEB J. 2006 . | ||||
Expression regulated by | |||||
Comment | |||||
Ovarian localization | Oocyte, Cumulus, Granulosa, Theca, Luteal cells, Stromal cells, Surface epithelium | ||||
Comment | Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice. Laws MJ 2014 et al. The etiology of ovarian epithelial cancer is poorly understood, mainly due to the lack of an appropriate experimental model for studying the onset and progression of this disease. We have created a mutant mouse model in which aberrant estrogen receptor alpha (ERa) signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis. In these mice, termed ERad/d, the ERa gene was conditionally deleted in the anterior pituitary, but remained intact in the hypothalamus and the ovary. The loss of negative-feedback regulation by estrogen (E) at the level of the pituitary led to increased production of luteinizing hormone (LH) by this tissue. Hyperstimulation of the ovarian cells by LH resulted in elevated steroidogenesis, producing high circulating levels of steroid hormones, including E. The ERad/d mice exhibited formation of palpable ovarian epithelial tumors starting at 5 months of age with 100% penetrance. By 15 months of age, 80% of ERad/d mice die. Besides proliferating epithelial cells, these tumors also contained an expanded population of luteinized stromal cells, which acquire the ability to express P450 aromatase and synthesize E locally. In response to the elevated levels of E, the ERa signaling was accentuated in the ovarian epithelial cells of ERad/d mice, triggering increased ERa-dependent gene expression, abnormal cell proliferation, and tumorigenesis. Consistent with these findings, treatment of ERad/d mice with letrozole, an aromatase inhibitor, markedly reduced circulating E and ovarian tumor volume. We have, therefore, developed a unique animal model, which serves as a useful tool for exploring the involvement of E-dependent signaling pathways in ovarian epithelial tumorigenesis. ///////////////////////// Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Hou Q et al. Estrogen and progesterone play an important role in the development and implantation of preimplantation embryos. However, it is controversial whether these hormones act directly on the embryos. The effects of these hormones depend on the existence of their specific receptors. To determine whether estrogen receptor (ER) and progesterone receptor genes are expressed in mouse preimplantation embryos, we examined RNA from embryos at different stages of preimplantation development by reverse transcription-polymerase chain reaction techniques. ER mRNA was found in oocytes and fertilized eggs. The message level began to decline at the two-cell stage and reached its lowest level at the five- to eight-cell stage. ER mRNA was not detectable at the morula stage but reappeared at the blastocyst stage. Progesterone receptor mRNA was not detectable until the blastocyst stage. The embryonic expression of ER and progesterone receptor genes in the blastocyst suggests a possible functional requirement for ER and progesterone receptor at this stage of development. These results provide a basis for determining the direct role of estrogen and progesterone in preimplantation embryos. Immunohistochemical localization of two estrogen receptor (ER) subtypes, ER beta and ER alpha, was performed in neonatal, early postnatal, immature, and adult rats to determine whether ER alpha and ER beta are differentially expressed in the ovary (Sar et al., 1999). ER alpha protein exhibited a differential distribution in the ovary with no detectable expression in the granulosa cells but evidence of ER alpha IR in germinal epithelium, interstitial cells, and thecal cells. | ||||
Follicle stages | Secondary, Antral, Preovulatory, Corpus luteum | ||||
Comment | |||||
Phenotypes |
POF (premature ovarian failure) |
||||
Mutations |
8 mutations
Species: mouse
Species: mouse
Species: human
Species: mouse
Species: mouse
Species: mouse
Species: human
Species: mouse
|
||||
Genomic Region | show genomic region | ||||
Phenotypes and GWAS | show phenotypes and GWAS | ||||
Links |
|
created: | July 22, 1999, midnight | by: |
Hsueh email:
home page: |
last update: | June 18, 2021, 10:24 a.m. | by: | hsueh email: |
Click here to return to gene search form